Leadership

Donna Ford-Serbu, CEO

Sector
Medical Devices

Eximis Surgical is a clinical stage medical device company developing a proprietary surgical technology for large specimen removal in minimally-invasive surgeries.

2023

April


Questa Led $8.7M Financing

2018

October


Questa Led $7.5M Financing

Eximis Surgical

“Some VCs look for an early exit and Questa is a little more flexible. They are not looking for a quick return and that patience is appreciated.”

Donna Ford-Serbu

CEO

Their story

Minimally invasive surgery (MIS) has transformed many areas of medicine, offering patients faster recovery and fewer complications. However, in gynecological procedures like hysterectomy and fibroid removal, MIS adoption has been limited due to the challenge of removing large excised tissues.

Eximis Surgical was founded by a team of medical device veterans to bridge this gap. The company is developing a technology that enables MIS for these complex procedures, expanding access to less invasive options for patients.

Recognizing the potential impact of this innovation, experienced med tech executives, including CEO Donna Ford-Serbu, joined the team to bring the solution to market. With a focus on overcoming key technical barriers, Eximis Surgical aims to redefine the standard of care in gynecological surgery.

Our partnership

Our long-standing relationship with the Eximis Surgical team and board gave us early insight into the challenge they set out to solve. The unmet need of enabling MIS in gynecological procedures has been recognized in the medical device community for years, but attempts to address it consistently stumbled. Around this time, we were also developing a proactive thesis on application and use cases for robotic surgery and felt that the company’s products could not only unlock MIS for gynecological surgeries, but also improve the case for robotic surgery in an important market. 

As a result of our work, we decided to partner with the company and have been advising and assisting them on their clinical and commercial efforts to advance its novel technology in this market.

"Our additional investment in Eximis Surgical reflects Questa's confidence in Donna and the team."

Ryan Drant, Founder & Managing Partner

Questa Capital